Literature DB >> 23430911

Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

Christiaan P Sentner1, Kadir Caliskan, Wim B Vletter, G Peter A Smit.   

Abstract

In glycogen storage disease type III (GSD III), deficiency of the debranching enzyme causes storage of an intermediate glycogen molecule (limit dextrin) in the affected tissues. In subtype IIIa hepatic tissue, skeletal- and cardiac muscle tissue is affected, while in subtype IIIb only hepatic tissue is affected. Cardiac storage of limit dextrin causes a form of cardiomyopathy, which resembles primary hypertrophic cardiomyopathy on cardiac ultrasound. We present a 32-year-old GSD IIIa patient with severe left ventricular hypertrophy (LVH) first diagnosed at the age of 8 years. LVH remained stable and symptomless until the patient presented at age 25 years with increasing dyspnea, fatigue, obesity, and NYHA (New York Heart Association) functional classification two out of four. Dyspnea, fatigue, and obesity progressed, and at age 28 years she was severely symptomatic with NYHA classification 3+ out of 4. On echocardiogram and electrocardiogram, the LVH had progressed as well. Initially, she was rejected for cardiac transplantation because of severe obesity. Therefore, a 900 cal, high protein diet providing 37% of total energy was prescribed during 4 months on which 10 kg weight loss was achieved. However, her symptoms as well as the electrocardiographic and echocardiographic LVH indices had improved dramatically - ultimately deferring cardiac transplantation. Thereafter, the caloric intake was increased to 1,370 cal per day, and the high protein intake was continued providing 43% of total energy. After 3 years of follow-up, the patient remains satisfied with reasonable exercise tolerance and minor symptoms in daily life.

Entities:  

Year:  2011        PMID: 23430911      PMCID: PMC3509915          DOI: 10.1007/8904_2011_111

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  20 in total

Review 1.  Glycogen storage diseases.

Authors:  Joseph I Wolfsdorf; David A Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy.

Authors:  H Akazawa; T Kuroda; S Kim; H Mito; T Kojo; K Shimada
Journal:  Eur Heart J       Date:  1997-03       Impact factor: 29.983

3.  Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis.

Authors:  S Kiechl; J Willeit; W Vogel; U Kohlendorfer; W Poewe
Journal:  Neuromuscul Disord       Date:  1999-10       Impact factor: 4.296

4.  Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet.

Authors:  Vassili Valayannopoulos; Fanny Bajolle; Jean-Baptiste Arnoux; Sandrine Dubois; Nathalie Sannier; Christiane Baussan; François Petit; Philippe Labrune; Daniel Rabier; Chris Ottolenghi; Anne Vassault; Christine Broissand; Damien Bonnet; Pascale de Lonlay
Journal:  Pediatr Res       Date:  2011-12       Impact factor: 3.756

5.  Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.

Authors:  B H Goodpaster; D E Kelley; R R Wing; A Meier; F L Thaete
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

6.  Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL.

Authors:  S Lucchiari; S Pagliarani; S Salani; M Filocamo; M Di Rocco; D Melis; C Rodolico; O Musumeci; A Toscano; N Bresolin; G P Comi
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

7.  Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III.

Authors:  P J Lee; J E Deanfield; M Burch; K Baig; W J McKenna; J V Leonard
Journal:  Am J Cardiol       Date:  1997-03-15       Impact factor: 2.778

8.  Cardiomyopathy of glycogen storage disease type III.

Authors:  J S Carvalho; E E Matthews; J V Leonard; J Deanfield
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

Review 9.  Glycogen storage disease in adults.

Authors:  G M Talente; R A Coleman; C Alter; L Baker; B I Brown; R A Cannon; Y T Chen; J F Crigler; P Ferreira; J C Haworth; G E Herman; R M Issenman; J P Keating; R Linde; T F Roe; B Senior; J I Wolfsdorf
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

10.  Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

Authors:  A I Dagli; R T Zori; H McCune; T Ivsic; M K Maisenbacher; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2009-03-30       Impact factor: 4.982

View more
  14 in total

1.  Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.

Authors:  Katalin M Ross; Iris A Ferrecchia; Kathryn R Dahlberg; Monika Dambska; Patrick T Ryan; David A Weinstein
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

2.  A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series.

Authors:  Isabelle Rousseau-Nepton; Minoru Okubo; Rosemarie Grabs; John Mitchell; Constantin Polychronakos; Celia Rodd
Journal:  CMAJ       Date:  2015-01-19       Impact factor: 8.262

Review 3.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

4.  Natural Progression of Canine Glycogen Storage Disease Type IIIa.

Authors:  Elizabeth D Brooks; Haiqing Yi; Stephanie L Austin; Beth L Thurberg; Sarah P Young; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

5.  Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III.

Authors:  Alessandra Brambilla; Savina Mannarino; Roberta Pretese; Serena Gasperini; Cinzia Galimberti; Rossella Parini
Journal:  JIMD Rep       Date:  2014-10-12

Review 6.  Investigation and management of the hepatic glycogen storage diseases.

Authors:  Kaustuv Bhattacharya
Journal:  Transl Pediatr       Date:  2015-07

7.  Glycogen storage disease type III: modified Atkins diet improves myopathy.

Authors:  Sebene Mayorandan; Uta Meyer; Hans Hartmann; Anibh Martin Das
Journal:  Orphanet J Rare Dis       Date:  2014-11-28       Impact factor: 4.123

Review 8.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

9.  Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.

Authors:  Christiaan P Sentner; Irene J Hoogeveen; David A Weinstein; René Santer; Elaine Murphy; Patrick J McKiernan; Ulrike Steuerwald; Nicholas J Beauchamp; Joanna Taybert; Pascal Laforêt; François M Petit; Aurélie Hubert; Philippe Labrune; G Peter A Smit; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2016-04-22       Impact factor: 4.982

Review 10.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.